{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:24:47Z","timestamp":1775291087835,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"MSD IDEA Middle East"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13300-021-01038-6","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T18:03:00Z","timestamp":1615399380000},"page":"1193-1207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Ebaa","family":"Al-Ozairi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahir K.","family":"Jallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Hafidh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalal M.","family":"Alhajeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eissa F. N.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6170-5085","authenticated-orcid":false,"given":"Zeyad","family":"Abd ElAal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysoon","family":"Loulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"1038_CR1","unstructured":"International Diabetes Federation. IDF diabetes atlas, 7th edn. Brussels, Belgium: International Diabetes Federation; 2015."},{"key":"1038_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics\u20142016 update. Circulation. 2016. https:\/\/doi.org\/10.1161\/CIR.0000000000000350.","journal-title":"Circulation"},{"key":"1038_CR3","unstructured":"American Heart Association. Cardiovascular disease & diabetes. http:\/\/www.heart.org\/HEARTORG\/Conditions\/Diabetes\/WhyDiabetesMatters\/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp\/#.V-Vy5U3rvwo. Accessed Mar 2019 n.d."},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"key":"1038_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc20-Sint","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142020. Diabetes Care. 2020;43:S1-2. https:\/\/doi.org\/10.2337\/dc20-Sint.","journal-title":"Diabetes Care"},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","volume":"373","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, K\u00f8ber LV, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med. 2015;373:2247\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1509225.","journal-title":"N Engl J Med"},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373:232\u201342. https:\/\/doi.org\/10.1056\/NEJMoa1501352.","journal-title":"N Engl J Med"},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.114.010389","volume":"130","author":"BM Scirica","year":"2014","unstructured":"Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, et al. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation. 2014;130:1579\u201388. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010389.","journal-title":"Circulation"},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"e000427","DOI":"10.1136\/bmjdrc-2017-000427","volume":"5","author":"HF Jelinek","year":"2017","unstructured":"Jelinek HF, Osman WM, Khandoker AH, Khalaf K, Lee S, Almahmeed W, et al. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. BMJ Open Diabetes Res Care. 2017;5:e000427. https:\/\/doi.org\/10.1136\/bmjdrc-2017-000427.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1038_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17:1\u201319. https:\/\/doi.org\/10.1186\/s12933-018-0728-6.","journal-title":"Cardiovasc Diabetol"},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","volume":"32","author":"K Iglay","year":"2016","unstructured":"Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32:1243\u201352. https:\/\/doi.org\/10.1185\/03007995.2016.1168291.","journal-title":"Curr Med Res Opin"},{"key":"1038_CR14","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.2337\/dc12-2451","volume":"36","author":"AM Channanath","year":"2013","unstructured":"Channanath AM, Farran B, Behbehani K, Thanaraj TA. State of diabetes, hypertension, and comorbidity in Kuwait: showcasing the trends as seen in native versus expatriate populations. Diabetes Care. 2013;36:e75\u2013e75. https:\/\/doi.org\/10.2337\/dc12-2451.","journal-title":"Diabetes Care"},{"key":"1038_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-019-1373-y","volume":"17","author":"M Nowakowska","year":"2019","unstructured":"Nowakowska M, Zghebi SS, Ashcroft DM, Buchan I, Chew-Graham C, Holt T, et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. 2019;17:1\u201310. https:\/\/doi.org\/10.1186\/s12916-019-1373-y.","journal-title":"BMC Med"},{"key":"1038_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3519093","author":"S Attal","year":"2019","unstructured":"Attal S, Mahmoud MH, Aseel MT, Candra A, Amuna P, Elnagmi M, et al. Indicators of quality of clinical care for type 2 diabetes patients in primary health care centers in Qatar: a retrospective analysis. Int J Endocrinol. 2019. https:\/\/doi.org\/10.1155\/2019\/3519093.","journal-title":"Int J Endocrinol"},{"key":"1038_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-019-0476-0","volume":"11","author":"A Bashier","year":"2019","unstructured":"Bashier A, Bin Hussain A, Abdelgadir E, Alawadi F, Sabbour H, Chilton R. Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases. Diabetol Metab Syndr. 2019;11:1\u201328. https:\/\/doi.org\/10.1186\/s13098-019-0476-0.","journal-title":"Diabetol Metab Syndr"},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2329-6607.1000650","volume":"11","author":"S Ellahham","year":"2020","unstructured":"Ellahham S. Diabetes and its associated cardiovascular complications in the Arabian Gulf: challenges and opportunities. J Clin Exp Cardiol. 2020;11:1\u20135. https:\/\/doi.org\/10.4172\/2329-6607.1000650.","journal-title":"J Clin Exp Cardiol"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-021-01038-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T22:40:16Z","timestamp":1616712016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-021-01038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01038-6","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}